hiv-infections

Documents about hiv-infections

• Dual Therapy Etravirine + Raltegravir by Once Daily in HIV-positive Patients (ETRAL QD)#890199ClinicalTrials.gov
• Body Compartment Pharmacokinetics of Anti- Retroviral Agents That May be Used for Future HIV Post- Exposure Prophylaxis.#892074ClinicalTrials.gov
• Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients#894390ClinicalTrials.gov
• Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients#903749ClinicalTrials.gov
• HIV disclosure patterns among sexually active adolescent girls and young women living with HIV in urban communities of Zambia#428731SUNScholar
• A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure#807558ClinicalTrials.gov
• A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs#882619ClinicalTrials.gov
• The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children#910258ClinicalTrials.gov
• Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults#279567ClinicalTrials.gov
• Experiences of patients living with HIV and AIDS on antiretroviral therapy in Accra, Ghana#637716SUNScholar
• Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)#907338ClinicalTrials.gov
• Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults#414339ClinicalTrials.gov
• Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)#801714ClinicalTrials.gov
• Botswana Pediatric Respiratory Disease and Bloodstream Infection Study#811624ClinicalTrials.gov
• Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users#842081ClinicalTrials.gov
• Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk Populations#865584ClinicalTrials.gov
• Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children#873408ClinicalTrials.gov
• Tailored Motivational Interviewing Implementation-Effectiveness Trial in Multidisciplinary Adolescent HIV Care Settings#875671ClinicalTrials.gov
• Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected Women#877018ClinicalTrials.gov
• Study to Improve Survival Among HIV-Exposed Infants in Botswana#906904ClinicalTrials.gov
• Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs#141043ClinicalTrials.gov
• A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3#123530ClinicalTrials.gov
• Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya#136391ClinicalTrials.gov
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion Vaccine#148588ClinicalTrials.gov
• Evolución de la coinfección por TB/VIH en la Región Metropolitana de Chile, 2005 a 2018#203305Repositorio UNAB
• A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients#245539ClinicalTrials.gov
• The impact of HIV and tuberculosis interventions on South African adult tuberculosis trends, 1990-2019 : a mathematical modeling analysis#316784SUNScholar
• Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults#405213ClinicalTrials.gov
• Informed Consent in Molecular HIV Epidemiology: A Rapid Review of the Literature to Identify Concerns and Recommendations.#431472PubMed
• Treatment of Oral Warts in HIV+ Patients#841796ClinicalTrials.gov
• Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients#887083ClinicalTrials.gov
• Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children#891035ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)#899337ClinicalTrials.gov
• The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients#905615ClinicalTrials.gov
• Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection#906420ClinicalTrials.gov
• Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Females#909608ClinicalTrials.gov
• Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022–2030:...#407422World Health Organization
• Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically#827499ClinicalTrials.gov
• Transfusion Safety Study (TSS)#896173ClinicalTrials.gov
• A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients#812872ClinicalTrials.gov
• A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment#830916ClinicalTrials.gov
• Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection#845657ClinicalTrials.gov
• A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women#862998ClinicalTrials.gov
• Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient#885834ClinicalTrials.gov
• IRF5-TNOP3 polymorphisms are associated with elite control of HIV infection: A retrospective study.#276170Repisalud
• Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults#303586ClinicalTrials.gov
• A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance#858445ClinicalTrials.gov
• A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs#895449ClinicalTrials.gov
• A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients#805829ClinicalTrials.gov
• Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers#865790ClinicalTrials.gov